Document Type

Patent

Publication Date

July 2014

Patent Number

8765119

CPC

A61K 35/28(20130101), A61K 35/51(20130101), A61K 2035/124(20130101), A61K 35/50(20130101), A61K 35/30(20130101), A61K 9/0085(20130101), C12N 5/0647(20130101), C12N 5/0663(20130101), C12N 5/0607(20130101), C12N 5/0675(20130101), C12N 2506/11(20130101)

Abstract

A method of treating a patient with a neurodegenerative disease, such as ALS, using progenitor cells isolated from human umbilical cord blood. Non-invasive transplantation of aldehyde dehydrogenase (ALDH+) expressing progenitor cells provides cell replacement and protection of motor neurons.

Application Number

10/908,322

Assignees

University of South Florida Saneron CCEL Therapeutics, Inc. StemCo Biomedical, Inc.

Filing Date

05/06/2005

Primary/U.S. Class

424/937

Share

COinS